Company / Shareholders' Equity
Baxter International Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$6.1B
FY2025
5-year range
$5.8B / $9.1B
FY2021-FY2025
Trend
-12.0%
vs FY2024
Sector context
#28 of 161
Health Care
What the data says
Baxter International's shareholders' equity of $6.1B is higher than 83% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 10 years, ranging from $5.8B in FY2022 to $9.1B in FY2017.
Based on SEC 10-K filings.
$6.1B in FY2025 with a 5-year CAGR of -6.7%. Top quartile in the Health Care sector.
Declined from $8.4B to $6.1B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- -6.7%
- 10-Year CAGR
- -
Sector benchmark
+21.0% above sector average
Key checks
Key Insights
- 5-year CAGR of -6.7%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 12.0% year-over-year.
- Ranks #28 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2017.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.1B | -12.0% |
| FY2024 | $7.0B | -17.1% |
| FY2023 | $8.4B | +44.0% |
| FY2022 | $5.8B | -35.7% |
| FY2021 | $9.1B | +4.5% |
| FY2020 | $8.7B | +10.2% |
| FY2019 | $7.9B | -13.1% |
| FY2018 | $9.1B | -0.6% |
| FY2017 | $9.1B | +10.1% |
| FY2016 | $8.3B | -6.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026